Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3928/19382359-20210421-02 http://scihub22266oqcxt.onion/10.3928/19382359-20210421-02 34044706!ä!34044706 Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=34044706&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Pediatr+Ann 2021 ; 50 (5): e222-e226 Nephropedia Template TP {{tp|p=34044706|t=2021. Immune Responses in Patients with COVID-19: An Overview |pdf=|usr=}}{{34044706}} gab.com Text Immune Responses in Patients with COVID-19: An Overview JO: Pediatr Ann http://www.kidney.de/pget.php?&tw=1&pmid=34044706 #FOAvip Since late 2019, the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection has resulted in more than 143 million confirmed infections and more than 3 million deaths worldwide (as of publication time). In this article, we discuss current knowledge of immune responses that confer protection to more than 80% of the people who have been infected and possible mechanisms by which the virus escapes immune surveillance in people who develop severe disease and those who die from the disease. We also discuss the differences in the immune responses by which, in most children, the infection results in only mild disease, although causing severe disease in some adults. Understanding these differences in both the innate and adaptive immune responses among these people can lead to the development of biotherapeutic treatment modalities that could modulate immune responses to offer protection against SARS-CoV-2 and block the ability of the virus to cause severe disease or death in humans. [Pediatr Ann. 2021;50(5):e222-e226.]. Twit Text FOAVip Immune Responses in Patients with COVID-19: An Overview ????Pediatr Ann http://www.kidney.de/pget.php?&tw=1&pmid=34044706 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34044706 #FOAvip English Wikipedia <ref>{{Cite pmid|34044706}}</ref> Immune Responses in Patients with COVID-19: An Overview #MMPMID34044706 Kamat D; Kamat A; Mathur A Pediatr Ann 2021[May]; 50 (5): e222-e226 PMID34044706show ga Since late 2019, the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection has resulted in more than 143 million confirmed infections and more than 3 million deaths worldwide (as of publication time). In this article, we discuss current knowledge of immune responses that confer protection to more than 80% of the people who have been infected and possible mechanisms by which the virus escapes immune surveillance in people who develop severe disease and those who die from the disease. We also discuss the differences in the immune responses by which, in most children, the infection results in only mild disease, although causing severe disease in some adults. Understanding these differences in both the innate and adaptive immune responses among these people can lead to the development of biotherapeutic treatment modalities that could modulate immune responses to offer protection against SARS-CoV-2 and block the ability of the virus to cause severe disease or death in humans. [Pediatr Ann. 2021;50(5):e222-e226.]. |COVID-19/*immunology[MESH] |Child[MESH] |Humans[MESH] |Immunity/*immunology[MESH]Immune Responses in Patients with COVID-19: An Overview (epmc).pdf DeepDyve Pubget Overpricing